Both have gone through clinical trials and the dosage schedule is set up in a way that is effective and safe for what they are used to treat
Important safety information, in line with the UK SmPC and MHRA guidance: Pancreatitis: semaglutide has been associated with a small increased risk of pancreatitis
Semaglutide is one type of active ingredient in glucagon-like peptide-1 (GLP-1) receptor agonist drugs, widely known as type 2 diabetes treatment (Ozempic) and weight loss medication for obesity (Wegovy)
For Southlake professionals who've tried compounded semaglutide or other approaches without reaching their goals, compounded tirzepatide offers a more powerful option under physician supervision
Symptoms of low blood sugar include: Shakiness and tremors Sudden sweating or chills Confusion or irritability Rapid heartbeat Fainting If you experience these symptoms, you should contact a healthcare professional immediately
Semaglutide activates GLP-1 receptors concentrated in the gut, pancreas, and brain